跳至主要内容
临床试验/NCT02159001
NCT02159001Unknown不适用

Efficacy and Cognitive Effects of Electroconvulsive Therapy in Clozapine-Resistant Schizophrenia

Niuvanniemi Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年6月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
1
主要终点
Positive and Negative Symptom Scale

研究概览

简要总结

Electroconvulsive therapy (ECT) is one of the oldest neuromodulation treatments still used in psychiatry. Only case reports and open label non-randomized studies have been published of ECT in clozapine-resistant schizophrenia patients. The purpose of this trial is to study the efficacy and cognitive effects of add-on ECT treatment (10-course) in schizophrenia patients taking clozapine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of schizophrenia or schizoaffective disorder
  • treatment-resistant to clozapine
  • age 18 - 64 years
  • capacity and willingness to give informed consent

排除标准

  • serious somatic illness
  • progressive neurological illness, recent brain damage or sequela of serious brain damage
  • ECT less than 3 months prior to this trial

结局指标

主要结局

Positive and Negative Symptom Scale

时间窗: 2 days

Positive and Negative Symptom Scale (PANSS) is assessed two days after ECT course

次要结局

未报告次要终点

研究者

发起方
Niuvanniemi Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验